XML 53 R40.htm IDEA: XBRL DOCUMENT v3.21.2
Licensed rights and other intangible assets - Summary of Information about License Rights and Other Intangible Assets, Net (Details) - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount $ 46,328 $ 45,674
Finite-Lived Intangible Assets, Accumulated Amortization 7,055 4,552
Finite-Lived Intangible Assets, Net 39,273 41,122
License Rights and Intangible Assets, Net, Gross Carrying Amount (Excluding Goodwill) 46,672 45,997
License rights and other intangible assets, net 39,617 41,445
Trademarks/trade name rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-Lived Intangible Assets, Gross Carrying Amount and Net 344 323
License rights [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 40,000 40,000
Finite-Lived Intangible Assets, Accumulated Amortization 6,070 3,803
Finite-Lived Intangible Assets, Net 33,930 36,197
Hormone therapy drug patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 4,732 4,045
Finite-Lived Intangible Assets, Accumulated Amortization 985 749
Finite-Lived Intangible Assets, Net 3,747 3,296
Hormone therapy drug candidate patents - applied and pending [Member]    
Finite-Lived Intangible Assets [Line Items]    
Finite-Lived Intangible Assets, Gross Carrying Amount 1,596 1,629
Finite-Lived Intangible Assets, Net $ 1,596 $ 1,629